Search - tctmd.com

Displaying 741 - 760 of 1344

Sort: Relevancy | Date

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

News Daily News

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Caitlin E. Cox

March 07, 2017

News Daily News

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Yael L. Maxwell

March 01, 2017

News Daily News

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Todd Neale

February 16, 2017

News Daily News

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Caitlin E. Cox

January 24, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Features

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

Yael L. Maxwell

January 16, 2017

News Daily News

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Caitlin E. Cox

December 21, 2016

News Daily News

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Michael O'Riordan

December 13, 2016

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

News Conference News AHA 2016

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

Michael O'Riordan

November 21, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Daily News

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Michael O'Riordan

November 09, 2016

Advertisement

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Anemia Common in ACS Patients, Linked with Higher Mortality

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content